| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $798K | +21.4% |
| SG&A Expense | $1.7M | +11.3% |
| Operating Income | -$2.5M | -14.3% |
| Pre-tax Income | -$4.1M | -41.5% |
| Net Income | -$4.1M | -41.5% |
| EPS (Basic) | -$3.77 | -4612.5% |
| EPS (Diluted) | -$3.77 | -20.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | +39.9% |
| Inventory | $50K | +0.0% |
| Current Assets | $118K | +67.9% |
| Total Assets | $322K | -3.3% |
| Current Liabilities | $3.6M | +76.1% |
| Long-term Debt | $2.5M | +10.0% |
| Total Liabilities | $3.7M | +67.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | +24.4% |
| Capital Expenditures | $860 | +0.0% |
| Investing Cash Flow | -$860 | +0.0% |
| Financing Cash Flow | $1.4M | -7.5% |
| Free Cash Flow | -$1.4M | +24.4% |
| Stockholders' Equity |
| -$3.4M |
| -79.3% |